References
- Bednarczuk T, Placha G, Jazdzewski K, et al. (2003). Interleukin-13 gene polymorphisms in patients with Graves' disease. Clin Endocrinol (Oxf), 59, 519–25
- Cao H, Lei S, Deng HW, Wang YP. (2012). Identification of genes for complex diseases using integrated analysis of multiple types of genomic data. PLoS One, 7, e42755
- Chong KK, Chiang SW, Wong GW, et al. (2008). Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Invest Ophthalmol Vis Sci, 49, 2409–15
- DerSimonian R, Laird N. (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177–88
- Granada M, Wilk JB, Tuzova M, et al. (2012). A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study. J Allergy Clin Immunol, 129, 840–5
- Guo J, Rapoport B, McLachlan SM. (1997). Thyroid peroxidase autoantibodies of IgE class in thyroid autoimmunity. Clin Immunol Immunopathol, 82, 157–62
- Hiromatsu Y, Fukutani T, Ichimura M, et al. (2005). Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease. J Clin Endocrinol Metab, 90, 296–301
- Inoue N, Watanabe M, Morita M, et al. (2011). Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases. Clin Exp Immunol, 163, 318–23
- Jang HW, Shin HW, Cho HJ, et al. (2011). Identification of HLA-DRB1 alleles associated with Graves' disease in Koreans by sequence-based typing. Immunol Invest, 40, 172–82
- Komiya I, Yamada T, Sato A, et al. (2001). Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13. J Clin Endocrinol Metab, 86, 3540–4
- Luo L, Cai B, Liu F, et al. (2012). Association of Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) C1858T gene polymorphism with susceptibility to autoimmune thyroid diseases: a meta-analysis. Endocr J, 59, 439–45
- Mantel N, Haenszel W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719–48
- Metcalfe R, Jordan N, Watson P, et al. (2002). Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry. J Clin Endocrinol Metab, 87, 1754–61
- Ofosu MH, Dunston G, Henry L, et al. (1996). HLA-DQ3 is associated with Graves' disease in African-Americans. Immunol Invest, 25, 103–10
- Pantelidis P, Jones MG, Welsh KI, et al. (2000). Identification of four novel interleukin-13 gene polymorphisms. Genes Immun, 1, 341–5
- Potaczek DP, Kabesch M. (2012). Current concepts of IgE regulation and impact of genetic determinants. Clin Exp Allergy, 42, 852–71
- Prabhakar BS, Bahn RS, Smith TJ. (2003). Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev, 24, 802–35
- Sato A, Takemura Y, Yamada T, et al. (1999). A possiblerole of immunoglobulinE in patients with hyperthyroid Graves' disease. J Clin Endocrinol Metab, 84, 3602–5
- Simmonds MJ, Heward JM, Franklyn JA, Gough SC. (2005). IL-13 and chromosome 5q31-q33: problems of identifying association within regions of linkage to Graves' disease. Clin Endocrinol (Oxf), 63, 695–7
- Tomer Y, Huber A. (2009). The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun, 32, 231–9
- Tomer Y. (2010). Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid, 20, 715–25
- Velaga MR, Wilson V, Jennings CE, et al. (2004). The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab, 89, 5862–5
- Vercelli D. (2002). Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol, 2, 389–93
- Weetman AP. (2000). Graves' disease. N Engl J Med, 343, 1236–48
- Wynn TA. (2003). IL-13 effector functions. Annu Rev Immunol, 21, 425–56
- Yamada T, Sato A, Komiya I, et al. (2000). An elevation of serum immunoglobulin Eprovides a newaspect of hyperthyroid Graves' disease. J Clin Endocrinol Metab, 85, 2775–8
- Yang Y, Lingling S, Ying J, et al. (2005). Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves' disease. J Hum Genet, 50, 574–82
- Yung E, Cheng PS, Fok TF, Wong GW. (2002). CTLA-4 gene A-G polymorphism and childhood Graves' disease. Clin Endocrinol (Oxf), 56, 649–53
- Zhu W, Liu N, Zhao Y, et al. (2010). Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease. J Endocrinol Invest, 33, 751–5